These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7786001)

  • 1. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.
    Winstanley PA; Mberu EK; Szwandt IS; Breckenridge AM; Watkins WM
    Antimicrob Agents Chemother; 1995 Apr; 39(4):948-52. PubMed ID: 7786001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
    Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
    Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum.
    Yeo AE; Seymour KK; Rieckmann KH; Christopherson RI
    Biochem Pharmacol; 1997 Apr; 53(7):943-50. PubMed ID: 9174107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.
    Nduati E; Hunt S; Kamau EM; Nzila A
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3652-7. PubMed ID: 16127035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.
    Zimmerman PA
    Am J Trop Med Hyg; 2003 Sep; 69(3):236-7. PubMed ID: 14628936
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
    Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug.
    Kinyanjui SM; Mberu EK; Winstanley PA; Jacobus DP; Watkins WM
    Am J Trop Med Hyg; 1999 Jun; 60(6):943-7. PubMed ID: 10403325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment.
    Curtis J; Duraisingh MT; Warhurst DC
    J Infect Dis; 1998 May; 177(5):1429-33. PubMed ID: 9593041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro.
    Yeo AE; Rieckmann KH
    Ann Trop Med Parasitol; 1997 Apr; 91(3):247-51. PubMed ID: 9229018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.
    Edstein MD; Bahr S; Kotecka B; Shanks GD; Rieckmann KH
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2300-1. PubMed ID: 9333069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
    Canfield CJ; Milhous WK; Ager AL; Rossan RN; Sweeney TR; Lewis NJ; Jacobus DP
    Am J Trop Med Hyg; 1993 Jul; 49(1):121-6. PubMed ID: 8352384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.
    Nzila AM; Nduati E; Mberu EK; Hopkins Sibley C; Monks SA; Winstanley PA; Watkins WM
    J Infect Dis; 2000 Jun; 181(6):2023-8. PubMed ID: 10837185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
    Cortese JF; Plowe CV
    Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of PS-15 in combination with sulfamethoxazole.
    Yeo AE; Rieckmann KH
    Trop Med Parasitol; 1994 Jun; 45(2):136-7. PubMed ID: 7939165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro.
    Scott HV; Rieckmann KH; O'Sullivan WJ
    Trans R Soc Trop Med Hyg; 1987; 81(5):715-21. PubMed ID: 3329779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors.
    Suling WJ; Seitz LE; Reynolds RC; Barrow WW
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4801-3. PubMed ID: 16251337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
    Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
    Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
    Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
    J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
    Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.